News

CVS Health reported stronger-than-expected second quarter earnings on Thursday, driven by a recovery in its Aetna insurance ...
The company raised its outlook as many insurers are struggling with elevated medical costs in the second quarter.
CVS Health reported second quarter total revenues increased to $98.9 billion, up 8.4% compared to the prior year period.
CVS Health reports Q2 earnings decline due to litigation charges but boost adjusted EPS guidance, highlighting transformation ...
Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...
Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.
CVS’s stock was having its best day in more than five months, amid strong growth in all of the company’s business units.
The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
The injunction is a loss for Gov. Sarah Sanders and a win for CVS, which previously said the state law likely would have ...
California’s health care purchaser expects to save $600 million over the five-year contract with CVS Caremark.